Correlation Between Demant AS and Orphazyme

By analyzing existing cross correlation between Demant AS and Orphazyme AS you can compare the effects of market volatilities on Demant AS and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Demant AS with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Demant AS and Orphazyme.

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both Demant AS and Orphazyme at the same time? Although using correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combing Demant AS and Orphazyme into the same portfolio which is an essential part of fundamental portfolio management process.

Diversification Opportunities for Demant AS and Orphazyme

<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>DA</div>
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>OR</div>

Pay attention - limited upside

The 3 months correlation between Demant and Orphazyme is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Demant AS and Orphazyme AS in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and Demant AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Demant AS are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of Demant AS i.e. Demant AS and Orphazyme go up and down completely randomly.

Pair Corralation between Demant AS and Orphazyme

If you would invest  9,700  in Orphazyme AS on April 28, 2020 and sell it today you would earn a total of  140.00  from holding Orphazyme AS or generate 1.44% return on investment over 30 days.
Time Period3 Months [change]
ValuesDaily Returns

Demant AS  vs.  Orphazyme AS

 Performance (%) 
Demant AS 

Demant AS Risk-Adjusted Performance

Over the last 30 days Demant AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Demant AS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short term losses for the investors.
Orphazyme AS 

Orphazyme Risk-Adjusted Performance

Over the last 30 days Orphazyme AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat weak basic indicators, Orphazyme may actually be approaching a critical reversion point that can send shares even higher in June 2020.

Demant AS and Orphazyme Volatility Contrast

Check out your portfolio center. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page